Canada Pension Plan Investment Board
KRYS icon

Canada Pension Plan Investment Board’s Krystal Biotech KRYS Stock Holding History

Canada Pension Plan Investment Board’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-600
Closed -$148K – 1870
2025
Q4 		$148K Hold
600
– – ﹤0.01% 1739
2025
Q3 		$106K Sell
600
-400
-40% -$59.9K ﹤0.01% 1188
2025
Q2 		$137K Sell
1,000
-300
-23% -$44.1K ﹤0.01% 1145
2025
Q1 		$234K Buy
+1,300
New +$219K ﹤0.01% 1035

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canada Pension Plan Investment Board's KRYS Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Krystal Biotech (KRYS) in Q1 2026, closing a stake of 600 shares — an estimated $148K sold.

Canada Pension Plan Investment Board first reported a position in KRYS in Q1 2025 and held it in 4 quarters. The position peaked at $234K in Q1 2025. 368 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Krystal Biotech position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 600 Krystal Biotech shares in Q1 2026, an estimated $148K.
  • Canada Pension Plan Investment Board first reported a position in Krystal Biotech in Q1 2025 and held it in 4 quarters.
  • Canada Pension Plan Investment Board's Krystal Biotech position peaked at $234K in Q1 2025.
  • 368 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.